This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Data availability
We have no data to deposit in a repository.
References
Huss R, Deeg HJ, Gooley T, Bryant E, Leisenring W, Clift R, et al. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia. Bone Marrow Transplant. 1996;18:767–76.
Hill RS, Petersen FB, Storb R, Appelbaum FR, Doney K, Dahlberg S, et al. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease. Blood. 1986;67:811–6.
Stern M, Passweg JR, Locasciulli A, Socié G, Schrezenmeier H, Békássy AN, et al. Influence of donor/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia. Transplantation. 2006;82:218–26. https://doi.org/10.1097/01.tp.0000226156.99206.d1.
Mochizuki K, Sugimori C, Qi Z, Lu X, Takami A, Ishiyama K, et al. Expansion of donor-derived hematopoietic stem cells with PIGA mutation associated with late graft failure after allogeneic stem cell transplantation. Blood. 2008;112:2160–2. https://doi.org/10.1182/blood-2008-02-141325.
Maruyama K, Aotsuka N, Kumano Y, Sato N, Kawashima N, Onda Y, et al. Immune-mediated hematopoietic failure after allogeneic hematopoietic stem cell transplantation: a common cause of late graft failure in patients with complete donor chimerism. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2018;24:43–49. https://doi.org/10.1016/j.bbmt.2017.08.018.
Kako S, Yamazaki H, Ohashi K, Ozawa Y, Ota S, Kanda Y, et al. Mixed chimerism and secondary graft failure in allogeneic hematopoietic stem cell transplantation for aplastic anemia. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2020;26:445–50. https://doi.org/10.1016/j.bbmt.2019.10.004.
Lawler M, McCann SR, Marsh JC, Ljungman P, Hows J, Vandenberghe E, et al. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA. Br J Haematol. 2009;144:933–45. https://doi.org/10.1111/j.1365-2141.2008.07533.x.
Hino T, Imi T, Hangaishi A, Kamoda Y, Iizuka H, Hirao M, et al. Escape hematopoiesis by donor-derived 6pLOH(+) hematopoietic stem cells in a marrow transplant recipient with late graft failure. Bone Marrow Transplant. 2019;54:1129–32. https://doi.org/10.1038/s41409-018-0420-1.
Desmond R, Townsley DM, Dumitriu B, Olnes MJ, Scheinberg P, Bevans M, et al. Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood. 2014;123:1818–25. https://doi.org/10.1182/blood-2013-10-534743.
Hosokawa K, Yamazaki H, Tanabe M, Imi T, Sugimori N, Nakao S. High-dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag. Leukemia. 2021;35:906–9. https://doi.org/10.1038/s41375-020-0950-6.
Stikvoort A, Gertow J, Sundin M, Remberger M, Mattsson J, Uhlin M. Chimerism patterns of long-term stable mixed chimeras posthematopoietic stem cell transplantation in patients with nonmalignant diseases: follow-up of long-term stable mixed chimerism patients. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2013;19:838–44. https://doi.org/10.1016/j.bbmt.2013.02.015.
Author information
Authors and Affiliations
Contributions
HK, KY, HS, HI, SO, MY, HU, TA, and SK treated the patient; HK and SN analyzed data, wrote, and revised the manuscript; TCD and YZ performed the experiment; and all authors reviewed the manuscript and approved it for the publication.
Corresponding authors
Ethics declarations
Competing interests
SN reports receiving honoraria from Kyowa-Kirin and Novartis. The other authors declare no conflicts of interest.
Ethical approval
The study protocol was approved by the Ethics Committee for Human Genome/Gene Analysis Research at Kanazawa University Graduate School of Medical Science and the institutional review board at Saga University Hospital. Informed consent was obtained from the patient for publication of the report.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Katsuya, H., Yamaguchi, K., Dung, T.C. et al. Late graft failure with donor-derived GPI-deficient cells in a mixed chimera following allogeneic bone marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 58, 465–468 (2023). https://doi.org/10.1038/s41409-023-01923-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-023-01923-7